
Thermo Fisher Scientific is updating its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to detect the omicron variant.
The panel is designed with a customizable menu of polymerase chain reaction (PCR) genotyping assays to identify known SARS-CoV-2 variants in over an hour, the company said. It is also compatible with real-time PCR instruments already commonly used in laboratories around the world.